DGAP-News 114 0 Kommentare APONTIS PHARMA AG: Notification on the implementation of stabilization measures

DGAP-News: APONTIS PHARMA AG / Key word(s): Miscellaneous
APONTIS PHARMA AG: Notification on the implementation of stabilization measures

10.06.2021 / 21:20
The issuer is solely responsible for the content of this announcement.

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.

10 June 2021

APONTIS PHARMA AG

Disclosure in accordance with Article 5 para. 4 lit. (b) and para. 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council on market abuse ("Market Abuse Regulation") of 16 April 2014 and in accordance with Article 6 para. 2 of the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 on the implementation of stabilisation measures

Following the pre-stabilisation announcement dated 29 April 2021, the stabilisation manager mentioned below has informed APONTIS PHARMA AG, Monheim am Rhein, Germany, (contact person: Sven Pauly; Telefon: +49 2173 89 55 4900) that stabilisations (within the meaning of Article 3 para. 2 lit. (d) of the Market Abuse Regulation) have taken place with respect to the offer of the following securities as indicated below:

The Securities:

Issuer:	APONTIS PHARMA AG
Guarantor (if applicable):	n/a
Aggregate nominal amount of the offer (excluding over-allotment option):	4,600,000
Description:	Ordinary shares with no par value ISIN DE000A3CMGM5
Offer price:	EUR 19.00

Stabilisation:

Stabilisation manager:	Hauck & Aufhäuser Privatbankiers Aktiengesellschaft
Existence, maximum size of the over-allotment option:	690,000 ordinary shares with no par value
Stabilisation marketplace:	Frankfurt Stock Exchange, Xetra (XETR)

Stabilisations:

Trade date and time	Purchase (P)/ Sale (S)	Nominal value (pieces)	Execution price (0.0000)	Currency code (ISO 4217)	Market place MIC (ISO 10386)
04.06.2021 09:36:49	P	290	17.1500	EUR	XETR
04.06.2021 09:36:49	P	10	17.3000	EUR	XETR
04.06.2021 09:58:04	P	6	17.3000	EUR	XETR
04.06.2021 09:58:04	P	294	17.2500	EUR	XETR
04.06.2021 10:29:44	P	345	17.2500	EUR	XETR
04.06.2021 10:29:44	P	5	17.3000	EUR	XETR
04.06.2021 10:59:34	P	1	17.4500	EUR	XETR
04.06.2021 10:59:34	P	47	17.5000	EUR	XETR
04.06.2021 10:59:34	P	419	17.3000	EUR	XETR
04.06.2021 10:59:34	P	283	17.3500	EUR	XETR
04.06.2021 12:14:43	P	400	17.3000	EUR	XETR
04.06.2021 12:15:00	P	435	17.4500	EUR	XETR
04.06.2021 12:15:00	P	15	17.5000	EUR	XETR
04.06.2021 12:20:09	P	804	17.5000	EUR	XETR
04.06.2021 12:20:09	P	518	17.7000	EUR	XETR
04.06.2021 12:20:09	P	228	17.6000	EUR	XETR
04.06.2021 12:20:37	P	950	17.7000	EUR	XETR
04.06.2021 12:20:58	P	450	17.7000	EUR	XETR
04.06.2021 12:23:36	P	400	17.2500	EUR	XETR
04.06.2021 12:26:40	P	978	17.2500	EUR	XETR
04.06.2021 12:28:57	P	1,122	17.5000	EUR	XETR
04.06.2021 12:34:38	P	280	17.5000	EUR	XETR
04.06.2021 12:36:47	P	1,820	17.7000	EUR	XETR
04.06.2021 12:44:34	P	482	17.6000	EUR	XETR
04.06.2021 12:46:51	P	718	17.5500	EUR	XETR
04.06.2021 13:35:12	P	427	17.4500	EUR	XETR
04.06.2021 13:35:12	P	303	17.6000	EUR	XETR
04.06.2021 13:35:12	P	438	17.3000	EUR	XETR
04.06.2021 13:35:12	P	215	17.5000	EUR	XETR
04.06.2021 13:37:26	P	17	17.2500	EUR	XETR
04.06.2021 13:40:01	P	600	17.3000	EUR	XETR
04.06.2021 13:42:58	P	700	17.3000	EUR	XETR
04.06.2021 14:17:11	P	300	17.3000	EUR	XETR
04.06.2021 14:17:11	P	246	17.4000	EUR	XETR
04.06.2021 14:17:11	P	439	17.2500	EUR	XETR
04.06.2021 14:17:11	P	399	17.2000	EUR	XETR
04.06.2021 14:19:16	P	116	17.1500	EUR	XETR
04.06.2021 14:33:55	P	300	17.4000	EUR	XETR
04.06.2021 14:34:04	P	17	17.5000	EUR	XETR
04.06.2021 14:34:04	P	283	17.4500	EUR	XETR
04.06.2021 15:22:49	P	3,100	17.5000	EUR	XETR
04.06.2021 16:36:10	P	800	17.5000	EUR	XETR
04.06.2021 17:36:01	P	8,000	17.6000	EUR	XETR
04.06.2021 17:36:01	P	5,000	17.6000	EUR	XETR
04.06.2021 17:36:01	P	5,000	17.6000	EUR	XETR
04.06.2021 17:36:01	P	10,000	17.6000	EUR	XETR
07.06.2021 16:33:16	P	3	17.9000	EUR	XETR
07.06.2021 16:33:16	P	286	17.8500	EUR	XETR
07.06.2021 16:33:16	P	81	18.0000	EUR	XETR
07.06.2021 16:33:16	P	400	17.9500	EUR	XETR
07.06.2021 16:33:16	P	327	17.7000	EUR	XETR
07.06.2021 16:33:16	P	3	17.8000	EUR	XETR
07.06.2021 17:36:09	P	3,000	18.0000	EUR	XETR
07.06.2021 17:36:09	P	10,000	18.0000	EUR	XETR
08.06.2021 09:02:07	P	500	18.0000	EUR	XETR
08.06.2021 09:02:07	P	1,500	18.0000	EUR	XETR
08.06.2021 10:08:03	P	78	17.8500	EUR	XETR
08.06.2021 10:08:03	P	522	17.8000	EUR	XETR
08.06.2021 11:48:08	P	442	17.8500	EUR	XETR
08.06.2021 11:48:08	P	413	17.6500	EUR	XETR
08.06.2021 11:48:08	P	645	17.6000	EUR	XETR
08.06.2021 11:48:41	P	209	17.8500	EUR	XETR
08.06.2021 11:48:41	P	691	17.6000	EUR	XETR
08.06.2021 17:18:41	P	29	17.9000	EUR	XETR
08.06.2021 17:18:41	P	1,171	17.8500	EUR	XETR
08.06.2021 17:30:10	P	200	17.8000	EUR	XETR
08.06.2021 17:30:37	P	800	17.8000	EUR	XETR
08.06.2021 17:30:37	P	285	17.8500	EUR	XETR
08.06.2021 17:30:37	P	115	17.9000	EUR	XETR
08.06.2021 17:36:09	P	10,000	17.9500	EUR	XETR
08.06.2021 17:36:09	P	20,000	17.9500	EUR	XETR
08.06.2021 17:36:09	P	20,000	17.9500	EUR	XETR
08.06.2021 17:36:09	P	20,000	17.9500	EUR	XETR
08.06.2021 17:36:09	P	1,000	17.9500	EUR	XETR
08.06.2021 17:36:09	P	10,000	17.9500	EUR	XETR
10.06.2021 10:36:50	P	801	17.6500	EUR	XETR
10.06.2021 10:36:50	P	263	17.7000	EUR	XETR
10.06.2021 12:42:42	P	33	17.8000	EUR	XETR
10.06.2021 12:42:42	P	781	17.8500	EUR	XETR
10.06.2021 12:45:37	P	10	17.8000	EUR	XETR
10.06.2021 12:45:37	P	956	17.8500	EUR	XETR
10.06.2021 12:45:37	P	961	17.9000	EUR	XETR
10.06.2021 12:45:37	P	156	17.9500	EUR	XETR
10.06.2021 13:14:37	P	353	17.9500	EUR	XETR
10.06.2021 13:14:37	P	26	18.0000	EUR	XETR
10.06.2021 14:28:37	P	500	17.7500	EUR	XETR
10.06.2021 14:28:37	P	344	17.9000	EUR	XETR
10.06.2021 14:28:37	P	24	17.9500	EUR	XETR
10.06.2021 17:36:25	P	25,000	18.2000	EUR	XETR

Sum	Aggregated volume (pieces)	Weighted price	Currency code (ISO 4217)
	180,908	17.8708	EUR

IMPORTANT NOTICE

These materials may not be, directly or indirectly, published, distributed or transmitted in or into the United States, Canada, Australia or Japan or any other jurisdiction in which the distribution or release would be unlawful. These materials do not constitute an offer of securities for sale or a solicitation of an offer to purchase securities (the "Securities") of Apontis Pharma AG (the "Company") in the United States, Australia, Canada, Japan or any other jurisdiction in which such offer or solicitation is unlawful. The Securities of the Company may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended (the "Securities Act"). There will be no public offering of the securities in the United States. The Securities of the Company have not been, and will not be, registered under the Securities Act. The securities referred to herein may not be offered or sold in Australia, Canada or Japan or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada or Japan subject to certain exceptions.

In the United Kingdom, this document is only being distributed to and is only directed at persons who (i) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"), or (ii) are persons falling within Article 49(2)(a) to (d) of the Order (high net worth companies, unincorporated associations, etc.), or (iii) to whom an invitation or inducement to engage in an investment activity (within the meaning of section 21 of the United Kingdom Financial Services and Markets Act 2000) in connection with the issue or sale of any securities may otherwise be lawfully communicated or caused to be communicated (all such persons together being referred to as "Relevant Persons"). This document is directed only at Relevant Persons and must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this document relates is available only to Relevant Persons and will be engaged in only with Relevant Persons.

This publication constitutes neither an offer to sell nor a solicitation to buy any securities. The securities have already been sold.

10.06.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:	English
Company:	APONTIS PHARMA AG
	Alfred-Nobel-Str. 10
	40789 Monheim
	Germany
E-mail:	info@apontis-pharma.de
Internet:	https://apontis-pharma.de/
ISIN:	DE000A3CMGM5
WKN:	A3CMGM
Listed:	Regulated Unofficial Market in Frankfurt (Scale)
EQS News ID:	1206816